Therapeutic targets in late-life psychoses: Review of concepts and critical issues

Schizophrenia Research

Volumn 27, Issue 2-3, 1997, Pages 227-239

  Soares, Jair C ^a   Gershon, Samuel ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Antipsychotics; Behavioral disturbances; Dementia; Late life; Psychosis

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CITALOPRAM; CLOZAPINE; DIBENZOXAZEPINE DERIVATIVE; DIPHENYLBUTYLPIPERIDINE DERIVATIVE; FLUOXETINE; HALOPERIDOL; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PHENOTHIAZINE DERIVATIVE; PLACEBO; PSYCHOTROPIC AGENT; RISPERIDONE; SERTINDOLE; THIORIDAZINE; THIOXANTHENE DERIVATIVE; TRAZODONE; ZIPRASIDONE;

CLINICAL TRIAL; CONFERENCE PAPER; CONFUSION; DELIRIUM; DELUSION; DEMENTIA; HUMAN; MOOD; NEUROLEPTIC MALIGNANT SYNDROME; ONSET AGE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SOMNOLENCE; TARDIVE DYSKINESIA;

AFFECTIVE DISORDERS, PSYCHOTIC; AGE FACTORS; AGE OF ONSET; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CITALOPRAM; DEMENTIA; HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEROTONIN UPTAKE INHIBITORS; TERMINOLOGY;

EID: 0030782296     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(97)00077-7     Document Type: Conference Paper

References (98)

1. Allen, R.L., Walker, Z., D'Ath, P. et al., 1995. Risperidone for psychotic and behavioral symptoms of Lewy body dementia. Lancet 346, 185.
2. Almeida, O.P., Howard, R.J., Levy, R. et al., 1995a. Psychotic states arising in late life (late paraphrenia): psychopathology and nosology. Br. J. Psychiatry 166, 205-214.
3. Almeida, O.P., Howard, R.J., Levy, R. et al., 1995b. Psychotic states arising in late life (late paraphrenia): the role of risk factors. Br. J. Psychiatry 166, 215-228.
4. Almeida, O.P., Levy, R., Howard, R.J. et al., 1996. Insight and paranoid disorders in late life (late paraphrenia). Int. J. Geriatr. Psychiatry 11, 653-658.
5. Alvir, J.M.J., Lieberman, J.A., Safferman, A.Z. et al., 1993. Clozapine-induced agranulocytosis-incidence and risk factors in the United States. New Engl. J. Med. 329, 162-167.
6. Anton, R.F., Burch, E.A., 1990. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am. J. Psychiatry 147, 1203-1208.
7. Baker, F.M., 1995. Misdiagnosis among older psychiatric patients. J. Natl. Med. Assoc. 87, 872-876.
8. Baldessarini, R.J., Cohen, B.M., Teicher, M.H., 1988. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychosis. Arch. Gen. Psychiatry 45, 79-91.
9. Baldwin, R.C., Jolley, D.J., 1986. The prognosis of depression in old age. Br. J. Psychiatry 149, 574-583.
10. Berman, I., Merson, A., Rachov-Pavlov, J. et al., 1996. Risperidone in elderly schizophrenic patients. Am. J. Geriatr. Psychiatry 4, 173-179.
11. Berrios, G.E., Brook, P., 1985. Delusions and the psychopathology of the elderly with dementia. Acta Psychiatr. Scand. 72, 296-301.
12. Bigelow, L.B., Kirch, D.G., Braun, T. et al., 1985. Absence of relationship of serum haloperidol concentrations and clinical response in chronic schizophrenia: a fixed-dose study. Psychopharmacol. Bull. 21, 66-68.
13. Bobinski, M., Wegiel, J., Wisniewski, H.M. et al., 1995. Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer's disease. Dementia 6, 205-210.
14. Breitner, B.C.C., Anderson, D.N., 1994. The organic and psychological antecedents of delusional jealousy in old age. Int. J. Geriatr. Psychiatry 9, 703-707.
15. Brodaty, H., Peters, K., Boyce, P. et al., 1991. Age and depression. J. Affect. Disord. 23, 137-149.
16. Brown, F.W., 1993. The neurobiology of late-life psychosis. Crit. Rev. Neurobiol. 7, 275-289.
17. Burke, W.J., Roccaforte, W.H., Wengel, S.P., 1988. Characteristics of elderly patients admitted for the first time to a psychiatric facility. J. Geriatr. Psychiatry Neurol. 1, 159-162.
18. Burns, A., Jacoby, R., Levy, R., 1990. Psychiatric phenomena in Alzheimer's disease, II: disorders of perception. Br. J. Psychiatry 157, 76-81, 92-94.
19. Bylsma, F.W., Folstein, M.F., Devanand, D.P. et al., 1994. Delusions and patterns of cognitive impairment in Alzheimer's disease. Neuropsychiatry Neuropsychol. Behav. Neurol. 7, 98-103.
20. Castle, D.J., Howard, R., 1992. What do we know about the aetiology of late-onset schizophrenia? Eur. Psychiatry 7, 1-9.
21. Champagne, L.L., Orengo, C.A., Kunik, M.E. et al, 1996. Psychosis in geropsychiatric inpatients with and without dementia. Int. J. Geriatr. Psychiatry 11, 523-527.
22. Chengappa, K.N., Baker, R.W., Kreinbrook, S.B. et al., 1995. Clozapine use in female geriatric patients with psychoses. J. Geriatr. Psychiatry Neurol. 8, 12-15.
23. Ciompi, L., 1980. Catamnestic long-term study of the course of life and aging of schizophrenics. Schizophr. Bull. 6, 606-618.
24. Dahl, S.G., 1986. Plasma level monitoring of antipsychotic drugs - clinical utility. Clin. Pharmacokin. 11, 36-61.
25. Davidson, M., Harvey, P., Welsh, K.A. et al., 1996. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease. Am. J. Psychiatry 153, 1274-1279.
26. Deutsch, L.H., Bylsma, F.W., Rovner, B.W. et al., 1991. Psychosis and physical aggression in probable Alzheimer's disease. Am. J. Psychiatry 148, 1159-1163.
27. Devanand, D.P., Cooper, T., Sackeim, H.A. et al., 1992. Low dose oral haloperidol and blood levels in Alzheimer's disease: a preliminary study. Psychopharmacol. Bull. 28, 169-173.
28. Devanand, D.P., Jacobs, D.M., Tang, M.X. et al., 1996. The course of psychopathologic features in mild to moderate Alzheimer disease. Arch. Gen. Psychiatry 54, 257-263.
29. Devanand, D.P., Sackeim, H.A., Brown, R.P. et al., 1989. A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease. Arch. Neurol. 46, 854-857.
30. Drevets, W.C., Rubin, E.H., 1989. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol. Psychiatry 25, 39-48.
31. Evans, J.D., Paulsen, J.S., Harris, M.J. et al., 1996. A clinical and neuropsychological comparison of delusional disorder and schizophrenia. J. Neuropsychiatry Clin. Neurosci. 8, 281-286.
32. Frankenburg, F.R., Kalunian, D., 1994. Clozapine in the elderly. J. Geriatr. Psychiatry Neurol. 7, 129-132.
33. Glazer, W.M., Morgenstern, H., Schooler, N. et al., 1990. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication. Br. J. Psychiatry 157, 585-592.
34. Gottfries, C.G., Nyth, A.L., 1991. Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia. Ann. NY Acad. Sci. 640, 276-279.
35. Grossberg, G.T., Manepalli, J., 1995. The older patient with psychotic symptoms. Psychiatr. Serv. 46, 55-59.
36. Hagger, C., Buckley, P., Kenny, J.T. et al., 1993. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol. Psychiatry 34, 702-712.
37. Holzer, J.C., Gitelman, D.R., Price, B.H., 1995. Efficacy of buspirone in the treatment of dementia with aggression. Am. J. Psychiatry 152, 812.
38. Houlihan, D.J., Mulsant, B.H., Sweet, R.A. et al., 1994. A naturalistic study of the treatment of behavioral complications of dementia. Am. J. Geriatr. Psychiatry 2, 78-85.
39. Howard, R., Meehan, O., Powell, R. et al., 1994. Successful treatment of Charles Bonnet syndrome type visual hallucinations with low-dose risperidone. Int. J. Geriatr. Psychiatry 9, 677-678.
40. Jackson, D.M., Ryan, C., Evenden, J. et al., 1994. Preclinical findings with new antipsychotic agents: what makes them atypical? Acta Psychiatr. Scand. 89 (Suppl. 380), 41-48.
41. Jeanblanc, W., Davis, Y.B., 1995. Risperidone for treating dementia-associated aggression. Am. J. Psychiatry 152, 1239.
42. Jeste, D.V., Caligiuri, M.P., Paulsen, J.S. et al., 1995a. Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 patients. Arch. Gen. Psychiatry 52, 756-765.
43. Jeste, D.V., Eastham, J.H., Lacro, J.P. et al., 1996. Management of late-life psychosis. J. Clin. Psychiatry 57 (Suppl. 3), 39-45.
44. Jeste, D.V., Harris, M.J., Krull, A. et al., 1995b. Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. Am. J. Psychiatry 152, 722-730.
45. Jeste, D.V., Lacro, J.P., Gilbert, P.L. et al., 1993. Treatment of late-life schizophrenia with neuroleptics. Schizophr. Bull. 19, 817-830.
46. Jorgensen, P., Munk-Jorgensen, P., 1985. Paranoid psychosis in the elderly: a follow-up study. Acta Psychiatr. Scand. 72, 358-363.
47. Kane, J.M., Woerner, M., Lieberman, J., 1988. Tardive dyskinesia: prevalence, incidence, and risk factors. J. Clin. Psychopharmacol. 8, 52S-56S.
48. Kaplan, R.M., Anderson, J.P., Wu, A.W. et al., 1989. The Quality of Well-Being Scale: applications in AIDS, cystic fibrosis, and arthritis. Med. Care 27, S27-S43.
49. Kendler, K.S., 1982. Demograph of paranoid psychoses (delusional disorder): a review and comparison with schizophrenia and affective illness. Arch. Gen. Psychiatry 39, 890-902.
50. Kerwin, R.W., 1994. The new atypical antipsychotics - a lack of extrapyramidal side-effects and new routes in schizophrenia research. Br. J. Psychiatry 164, 141-148.
51. Kraepelin, E., 1919. Paraphrenia. In: Kraepelin, E. (Ed.), Dementia Praecox and Paraphrenia. Robert E. Krieger, New York, pp. 282-328.
52. Krishnan, K.R.R., 1991. Organic bases of depression in the elderly. Annu. Rev. Med. 42, 261-266.
53. Lacro, J.P., Eastham, J.H., Gilbert, P. et al., 1996. Risperidone treatment in old patients with psychosis. Presented at the 36th NCDEU meeting, 28-31 May, Boca Raton, FL.
54. Lee, H., Cooney, J.M., Lawlor, B.A., 1994. The use of risperidone, an atypical neuroleptic, in Lewy body disease. Int. J. Geriatr. Psychiatry 9, 415-417.
55. Lesser, I.M., Boone, K.B., Mehringer, M. et al., 1996. Cognition and white matter hyperintensities in older depressed patients. Am. J. Psychiatry 153, 1280-1287.
56. Lindstrom, L.H., 1994. Long-term clinical and social outcome studies in schizophrenia in relation to cognitive and emotional side-effects of antipsychotic drugs. Acta Psychiatr. Scand. 89, 74-76.
57. Madhusoodanan, S., Brenner, R., Araujo, L. et al., 1995. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J. Clin. Psychiatry 56, 514-518.
58. Manschreck, T.C., 1992. Delusional disorders: clinical concepts and diagnostic strategies. Psychiatr. Ann. 22, 241-251.
59. McEvoy, J.P., McCue, M., Spring, B. et al., 1987. Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers. Am. J. Psychiatry 144, 573-577.
60. Meco, G., Alessandria, A., Bonifati, V. et al., 1994. Risperidone for hallucinations in levodopa-treated Parkinson's disease patients. Lancet 343, 1370-1371.
61. Meyers, B.S., Greenberg, R., 1986. Late-life delusional depression. J. Affect. Disord. 11, 133-137.
62. Miller, B.L., Lesser, I.M., 1988. Late-life psychosis and modern neuroimaging. Psychiatr. Clin. North Am. 11, 33-46.
63. Mulsant, B.H., Gershon, S., 1993. Neuroleptics in the treatment of psychosis in late life: a rational approach. Int. J. Geriatr. Psychiatry 8, 979-992.
64. Murphy, E., 1983. The prognosis of depression in old age. Br. J. Psychiatry 142, 111-119.
65. Musser, W.S., Akil, M., 1996. Clozapine as a treatment for psychosis in Parkinson's disease: a review. J. Neuropsychiatry Clin. Neurosci. 8, 1-9.
66. Naber, D., Holzbach, R., Perro, C. et al., 1992. Clinical management of clozapine patients in relation to efficacy and side-effects. Br. J. Psychiatry 160, 54-59.
67. Nemeroff, C.B., DeVane, C.L., Pollock, B.G., 1996. Newer anti-depressants and the cytochrome P450 system. Am. J. Psychiatry 153, 311-320.
68. Nyth, A.L., Gottfries, C.G., 1990. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. Br. J. Psychiatry 157, 894-901.
69. Pearlson, G.D., Kreger, L., Rabins, P.V. et al., 1989. A chart review study of late-onset and early-onset schizophrenia. Am. J. Psychiatry 146, 1568-1574.
70. Pearlson, G.D., Rabins, P.V., 1988. Psychosis and depression in the elderly; the late-onset psychoses: possible risk factors. Psychiatr. Clin. North Am. 2, 15-31.
71. Pollock, B.G., 1994. Recent developments in drug metabolism of relevance to psychiatrists. Harv. Rev. Psychiatry 2, 204-213.
72. Post, F., 1966. Persistent Persecutory States of the Elderly. Pergamon Press, Oxford.
73. Raskind, M.A., Risse, S.C., 1986. Antipsychotic drugs and the elderly. J. Clin. Psychiatry 47 (Suppl.), 17-22.
74. Ray, W.A., Griffin, M.R., Schaffner, W. et al., 1987. Psychotropic drug use and the risk of hip fracture. New Engl. J. Med. 316, 363-369.
75. Reynolds, C.F., Frank, E., Kupfer, D.J. et al., 1996. Treatment outcome in recurrent major depression: a post hoc comparison of elderly ('young old') and midlife patients. Am. J. Psychiatry 153, 1288-1292.
76. Reynolds, C.F., Frank, E., Perel, J.M. et al., 1992. Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report. Am. J. Psychiatry 149, 1687-1692.
77. Rich, S.S., Friedman, J.H., Ott, B.R., 1995. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes. J. Clin. Psychiatry 56, 556-559.
78. Rosen, J., Bohon, S., Gerson, S.C., 1990. Antipsychotics in the elderly. Acta Psychiatr. Scand. 82, 170-175.
79. Rosen, J., Zubenko, G.S., 1991. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease. Biol. Psychiatr. 29, 224-232.
80. Saltz, B.L., Kane, J.M., Woerner, M.G. et al., 1989. Prospective study of tardive dyskinesia in the elderly. Psychopharmacol. Bull. 25, 52-56.
81. Salzman, C., Vaccaro, B., Lieff, J. et al., 1995. Clozapine in older patients with psychosis and behavioral disruption. Am J. Geriatr. Psychiatry 3, 26-33.
82. Schneider, L.S., Sobin, P.B., 1991. Non-neuroleptic medications in the management of agitation in Alzheimer's disease and other dementia: a selective review. Int. J. Geriatr. Psychiatry 6, 691-708.
83. Schuster, P., Gabriel, E., Kufferle, B., 1977. Reversal by physostigmine of clozapine-induced delirium. Clin. Toxicol. 10, 437-441.
84. Smith, J.M., Baldessarini, R.J., 1980. Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch. Gen. Psychiatry 37, 1368-1373.
85. Soares, J.C., Mann, J.J., 1997. The neuroanatomy of mood disorders - review of structural neuroimaging studies. Biol. Psychiatry 41, 86-106.
86. Spiker, D.G., Weiss, J.C., Dealy, R.S. et al., 1985. The pharmacological treatment of delusional depression. Am. J. Psychiatry 142, 430-436.
87. Steinberg, J.R., 1994. Anxiety in elderly patients: a comparison of azapirones and benzodiazepines. Drugs Aging 5, 335-345.
88. Stern, Y., Albert, M., Brandt, J. et al., 1994. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology 44, 2300-2307.
89. Stern, Y., Folstein, M., Albert, M. et al., 1993. Multicenter study of predictors of disease course in Alzheimer disease (the 'Predictors Study'), I: study design, cohort description, and intersite comparisons. Alzheimer Dis. Assoc. Disord. 7, 3-21.
90. Sweet, R.A., Mulsant, B.H., Rifai, A.H. et al., 1992. Dyskinesia and neuroleptic exposure in elderly psychiatric inpatients. J. Geriatr. Psychiatry Neurol. 5, 156-161.
91. Thienhaus, O.J., Allen, A., Bennett, J.A. et al., 1990. Anticholinergic serum levels and cognitive performance. Eur. Arch. Psychiatry Neurol. Sci. 240, 28-33.
92. Tinetti, M.E., Speechley, M., Ginter, S.F., 1988. Risk factor for falls among elderly persons living in the community. New Engl. J. Med. 319, 1701-1707.
93. Wilson, J.A., MacLennan, W.J., 1989. Review: drug-induced parkinsonism in elderly patients. Age Ageing 18, 208-210.
94. Wilson, J.A., Primrose, W.R., Smith, R.G., 1987. Prognosis of drug induced Parkinson's disease. Lancet 1, 443-444.
95. Wragg, R.E., Jeste, D.V., 1988. Neuroleptics and alternative treatments: management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions. Psychiatr. Clin. North Am. 11, 195-213.
96. Wragg, R.E., Jeste, D.V., 1989. Overview of depression and psychosis in Alzheimer's disease. Am. J. Psychiatry 146, 577-587.
97. Yassa, R., Suranyi-Cadotte, B., 1993. Clinical characteristics of late onset schizophrenia and delusional disorder. Schizophr. Bull. 19, 701-707.
98. Zubenko, G.S., Moossy, J., Martinez, A.J. et al., 1991. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch. Neurol. 48, 619-624 [published erratum appears in Arch. Neurol. 1992, 49, 1064].